DocDollars

Akebia Therapeutics Inc

MA · United States · Reporting entity ID 100000521827

Total reported 2019–2025
$89.4M
#105 of 2,960 reporting companies — 0.1% of all reported industry payments
$6.09M in general payments across 39,690 records, plus $83.3M in research funding across 61,492 records.

How it breaks down

General payments $6,086,254
Research funding $83,274,264

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Akebia Therapeutics Inc reported $89.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #105 of 2,960 reporting companies. 93% of that was research funding and 7% general payments such as consulting, speaking, food and travel. 39,690 general payment records and 61,492 research records were filed.

Common questions about Akebia Therapeutics Inc

How much has Akebia Therapeutics Inc paid US doctors?

Akebia Therapeutics Inc reported $89,360,518 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,086,254 in general payments, $83,274,264 in research funding.

How does Akebia Therapeutics Inc rank among drug and device companies?

It ranks #105 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Akebia Therapeutics Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.